Bank of New York Mellon »

Cerevel Therapeutics Hldng I shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-03-31 $12M 290k 42.27
2023-12-31 $13M 311k 42.40
2023-09-30 $5.8M 264k 21.83
2023-06-30 $8.3M 260k 31.79
2023-03-31 $5.7M 236k 24.39
2022-12-31 $7.4M 235k 31.54
2022-09-30 $6.4M 226k 28.26
2022-06-30 $5.5M 209k 26.44
2022-03-31 $14M 407k 35.01
2021-12-31 $14M 440k 32.47
2021-09-30 $13M 423k 29.50
2021-06-30 $9.8M 383k 25.62
2021-03-31 $11M 831k 13.73
2020-12-31 $359k 22k 16.59